In prostate cancer, androgen receptors synergistically regulate the expression of ACSL3 and ACSL4, and knocking out ACSL4 inhibits the proliferation, migration, invasion, and xenograft growth of androgen receptor dependent prostate cancer cells (50). This evidence concerns the gene AR and prostate cancer.